Diluted HEPS increased by 31.6% y-y to 120.3cps. Revenue growth of +7.6% y-y to R5 917m. EBITDA improved, increasing 121bps to 24%. Expenses well maintained, expense to revenue ratio decreasing by 121bps to 76%. Dividend declared: 50.0cps (FY20: 20.0) with a dividend cover of 2.4x. Gross debt decreased by 20%. 30% reduction in net financing cost due to reduction in net borrowings and low interest rates
